Artonius Panagiotakis
Obstetrics & Gynecology · Stamford, CTNPI 1083853550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 33.7% of the total. Among obstetrics & gynecology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Mayne Pharma Commercial LLC$517
- Coopersurgical, Inc.$328
- Avion Pharmaceuticals$319
- Sumitomo Pharma America, Inc.$243
- Pfizer$234
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,49298%
- Education$862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 94 | $1,881 |
| Mayne Pharma Commercial LLC | 23 | $517 |
| Coopersurgical, Inc. | 17 | $328 |
| Avion Pharmaceuticals | 25 | $319 |
| Sumitomo Pharma America, Inc. | 12 | $243 |
| Pfizer | 13 | $234 |
| Exact Sciences | 9 | $230 |
| Therapeuticsmd, Inc. | 9 | $152 |
| Bayer | 7 | $142 |
| Lupin Inc. | 7 | $141 |
| Agile Therapeutics, Inc. | 6 | $126 |
| Biogen | 5 | $124 |
| Merck | 6 | $115 |
| AMAG Pharmaceuticals, Inc. | 5 | $86 |
| Millicent US Inc | 5 | $84 |
| Organon | 4 | $84 |
| Conmed Corporation | 2 | $78 |
| Astellas Pharma US Inc | 4 | $62 |
| Mylan Pharmaceuticals Inc. | 4 | $61 |
| Aspira Women's Health Inc | 3 | $60 |
| Exeltis, USA Inc. | 4 | $60 |
| Scynexis, Inc. | 2 | $58 |
| Medicem Inc. | 4 | $58 |
| Hologic Sales And Service, LLC | 2 | $53 |
| Vertical Pharmaceuticals, LLC | 3 | $52 |
| Medtronic | 2 | $51 |
| Evofem Biosciences, Inc. | 2 | $42 |
| Myovant Sciences Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Meditrina | 1 | $19 |
| Mission Pharmacal Company | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$5,578 in reported general payments places this provider in the 90th percentile of 605 obstetrics & gynecology providers in Connecticut.
Other obstetrics & gynecology in Stamford
- Shieva GhofranyStamford$33K
- Sarp AkselStamford$22K
- Daniel CibulskyStamford$17K
- Patrick CahillStamford$8K
- Gary BesserStamford$8K
- George HeadingStamford$8K
- Astrid Hoffmann-OlsenStamford$7K
- Robert GennaroStamford$7K
- David WeinsteinStamford$6K
- Stephanie GoldpinStamford$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.